These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25735330)

  • 1. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
    Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
    Jiang H; Dai J; Huang X; Chen Y; Qu P; Li J; Yi C; Yang Y; Zhang K; Huang Q
    Sci Rep; 2015 Mar; 5():9536. PubMed ID: 25826294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.
    Jin X; Zhang KJ; Guo X; Myers R; Ye Z; Zhang ZP; Li XF; Yang HS; Xing JL
    Asian Pac J Cancer Prev; 2014; 15(17):7097-103. PubMed ID: 25227797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
    Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
    Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
    Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
    Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
    Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
    Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
    Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
    Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
    Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
    Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
    Wang XC; Wang F; Quan QQ
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
    Song Y; Xing H; Zhou L; Zhang N; Yang M
    Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
    Yu X; Ge N; Guo X; Shen S; Liang J; Huang X; Wan S; Xing J; Huang Q; Yang Y
    PLoS One; 2014; 9(4):e93416. PubMed ID: 24718422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
    Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
    Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
    Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
    Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
    Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
    Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
    Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
    Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
    Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.